PTH vs. CURE
PTH (Invesco DWA Healthcare Momentum ETF) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both exchange-traded funds - PTH is a Momentum fund tracking the Dorsey Wright Healthcare Technical Leaders Index, while CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, PTH returned 14.65%/yr vs 14.03%/yr for CURE. A 0.67 correlation means they provide meaningful diversification when combined. PTH charges 0.60%/yr vs 1.08%/yr for CURE.
Performance
PTH vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PTH achieves a 10.66% return, which is significantly higher than CURE's -10.45% return. Both investments have delivered pretty close results over the past 10 years, with PTH having a 14.65% annualized return and CURE not far behind at 14.03%.
PTH
- 1D
- 0.84%
- 1M
- 7.38%
- YTD
- 10.66%
- 6M
- 8.96%
- 1Y
- 47.97%
- 3Y*
- 12.29%
- 5Y*
- 0.29%
- 10Y*
- 14.65%
CURE
- 1D
- 3.78%
- 1M
- 4.14%
- YTD
- -10.45%
- 6M
- -10.93%
- 1Y
- 35.07%
- 3Y*
- 1.46%
- 5Y*
- 0.46%
- 10Y*
- 14.03%
PTH vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PTH Invesco DWA Healthcare Momentum ETF | 10.66% | 27.91% | 2.36% | -4.54% | -20.61% | -3.20% | 67.26% | 34.45% | -1.23% | 50.15% |
CURE Direxion Daily Healthcare Bull 3x Shares | -10.45% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between PTH and CURE is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.47 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.53 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.60 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.62 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.67 |
The correlation between PTH and CURE shifts across timeframes, from 0.47 (1 year) to 0.67 (all time), reflecting how their relationship changes across market environments.
PTH vs. CURE - Sectors Allocation Comparison
Sectors
PTH
CURE
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PTH
CURE
Financial Services
PTH
CURE
-
Basic Materials
PTH
-
CURE
-
Communication Services
PTH
-
CURE
-
Consumer Cyclical
PTH
-
CURE
-
Consumer Defensive
PTH
-
CURE
-
Energy
PTH
-
CURE
-
Industrials
PTH
-
CURE
-
Real Estate
PTH
-
CURE
-
Technology
PTH
-
CURE
-
Utilities
PTH
-
CURE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PTH vs. CURE — Risk / Return Rank
PTH
CURE
PTH vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco DWA Healthcare Momentum ETF (PTH) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PTH | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.21 | ||
| Sortino ratioReturn per unit of downside risk | +1.36 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.16 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 4.02 | 1.13 | +2.89 |
| Martin ratioReturn relative to average drawdown | 10.05 | 2.51 | +7.54 |
Loading charts...
Drawdowns
PTH vs. CURE - Drawdown Comparison
The maximum PTH drawdown since its inception was -53.52%, smaller than the maximum CURE drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for PTH and CURE.
Loading charts...
Drawdown Indicators
| PTH | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -53.52% | -69.19% | +15.67% |
Max Drawdown (1Y)Largest decline over 1 year | -11.98% | -31.10% | +19.12% |
Max Drawdown (3Y)Largest decline over 3 years | -28.09% | -51.93% | +23.84% |
Max Drawdown (5Y)Largest decline over 5 years | -50.07% | -52.23% | +2.16% |
Max Drawdown (10Y)Largest decline over 10 years | -53.52% | -69.19% | +15.67% |
Current DrawdownCurrent decline from peak | -9.70% | -28.92% | +19.22% |
Average DrawdownAverage peak-to-trough decline | -16.99% | -18.18% | +1.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.79% | 13.98% | -9.19% |
Volatility
PTH vs. CURE - Volatility Comparison
The current volatility for Invesco DWA Healthcare Momentum ETF (PTH) is 9.29%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 15.41%. This indicates that PTH experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PTH | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.29% | 15.41% | -6.12% |
Volatility (6M)Calculated over the trailing 6-month period | 18.85% | 31.09% | -12.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.06% | 44.49% | -20.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.57% | 43.92% | -18.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.30% | 49.58% | -22.28% |
PTH vs. CURE - Expense Ratio Comparison
PTH has a 0.60% expense ratio, which is lower than CURE's 1.08% expense ratio.
Dividends
PTH vs. CURE - Dividend Comparison
PTH's dividend yield for the trailing twelve months is around 2.78%, more than CURE's 1.19% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.19% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
PTH Invesco DWA Healthcare Momentum ETF | 2.78% | 3.07% | 0.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
PTH and CURE have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (15.41%) compared to PTH (9.29%). In terms of maximum drawdown, PTH dropped -53.52% vs CURE's -69.19%.
On 10-year performance, PTH leads with 14.65% vs 14.03% for CURE. On fees, PTH is cheaper at 0.60% per year. On volatility, PTH has been the lower-risk option at 9.29%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, PTH has performed better with a 14.65% return vs 14.03%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PTH is cheaper with a 0.60% expense ratio, compared with 1.08% for CURE.
PTH has the higher dividend yield at 2.78%, compared with 1.19% for CURE.
PTH is categorized as Momentum, while CURE is Leveraged Equities. PTH tracks Dorsey Wright Healthcare Technical Leaders Index, while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: Invesco and Direxion. Their fees differ too: 0.60% for PTH and 1.08% for CURE.
PTH currently has the higher Sharpe Ratio (2.00 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PTH and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer